CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-07 | Waddill William D. Director | Grant or award | +6,400 | 32,150 | ||
| 2022-01-07 | PERRY MICHAEL S Director | Grant or award | +6,400 | 91,900 | ||
| 2022-01-07 | OLUKOTUN ADEOYE Y Director | Grant or award | +6,400 | 11,350 | ||
| 2022-01-07 | GIVEN DOUGLAS B Director | Grant or award | +6,400 | 116,268 | ||
| 2022-01-07 | Ferrari Mauro Director | Grant or award | +6,400 | 42,971 | ||
| 2022-01-07 | De Backer Marianne Director | Grant or award | +6,400 | 23,400 | ||
| 2022-01-05 | O'Brien Patrick General Counsel | Sale | −12,434 | $60.49 | $752K | 368,941 |
| 2022-01-05 | O'Brien Patrick General Counsel | Sale | −10,350 | $61.88 | $640K | 358,591 |
| 2022-01-05 | O'Brien Patrick General Counsel | Sale | −5,000 | $62.49 | $312K | 353,591 |
| 2022-01-05 | O'Brien Patrick General Counsel | Sale | −4,400 | $63.75 | $281K | 349,191 |
| 2022-01-05 | O'Brien Patrick General Counsel | Sale | −316 | $64.35 | $20K | 348,875 |
| 2022-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −15,908 | $60.50 | $962K | 488,097 |
| 2022-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −16,528 | $62.00 | $1.0M | 471,569 |
| 2022-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −3,778 | $63.17 | $239K | 467,791 |
| 2022-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −3,786 | $63.95 | $242K | 464,005 |
| 2022-01-05 | Hamilton James C Senior Vice President | Sale | −2,290 | $60.51 | $139K | 159,585 |
| 2022-01-05 | Hamilton James C Senior Vice President | Sale | −2,100 | $61.84 | $130K | 157,485 |
| 2022-01-05 | Hamilton James C Senior Vice President | Sale | −1,100 | $62.64 | $69K | 156,385 |
| 2022-01-05 | Hamilton James C Senior Vice President | Sale | −700 | $63.68 | $45K | 155,685 |
| 2022-01-05 | Hamilton James C Senior Vice President | Sale | −60 | $64.35 | $4K | 155,625 |
Page 15 of 38 · 752 trades